ResearcherLandeskrankenhaus FeldkirchNo recent work listed

Ingmar Königsrainer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8949-0389; OpenAlex author ID A5078271063. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic A… Co-author DOI 10.1245/s10434-021-10187-8 ↗
Do patient- and tumor-related factors predict the peritoneal spread of pancreatic adenocarcinoma? Co-author DOI 10.1007/s00595-013-0546-0 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stefan Beckert · 2 shared papers, 2014–2021 · strength 0.18
- Paper A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy Aft… DOI 10.1245/s10434-021-10187-8 ↗
- Paper Do patient- and tumor-related factors predict the peritoneal spread of pancreatic adenocarcinoma? DOI 10.1007/s00595-013-0546-0 ↗
Can Yurttas · 1 shared paper, 2021 · strength 0.13
- Paper A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy Aft… DOI 10.1245/s10434-021-10187-8 ↗
Markus W. Loeffler · 1 shared paper, 2021 · strength 0.13
- Paper A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy Aft… DOI 10.1245/s10434-021-10187-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.